If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 66   2005   NUMBER 5

Editorial

554 Funding, Conflicts, and Paradigms. Alan J. Gelenberg
[PDF]

Original Articles

555 Carnitine Levels in Valproic Acid-Treated Psychiatric Patients: A Cross-Sectional Study. Francisco A. Moreno, Helen Macey, and Brian Schreiber
[Abstract] [PDF]

559 A 4-Fold Risk of Metabolic Syndrome in Patients With Schizophrenia: The Northern Finland 1966 Birth Cohort Study. Kaisa M. Saari, Sari M. Lindeman, Kaisa M. Viilo, Matti K. Isohanni, Marjo-Riitta Järvelin, Liisa H. Laurén, Markku J. Savolainen, and Hannu J. Koponen
[Abstract] [PDF]

564 Comorbidity of DSM-IV Pathological Gambling and Other Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. [CME] Nancy M. Petry, Frederick S. Stinson, and Bridget F. Grant
[Abstract] [PDF]

575 An Open-Label Study of Amisulpride in the Treatment of Mania. Eduard Vieta, Salvador Ros, José Manuel Goikolea, Antonio Benabarre, Ekaterina Popova, Mercè Comes, Jorge Capapey, and José Sánchez-Moreno
[Abstract] [PDF]

579 Risk Factors for Completed Suicide in Schizophrenia. [CME] Chian-Jue Kuo, Shang-Ying Tsai, Chun-Hsuan Lo, Ying-Ping Wang, and Chiao-Chicy Chen
[Abstract] [PDF]

586 Controlled Double-Blind Trial of Phenytoin vs. Fluoxetine in Major Depressive Disorder. Boris Nemets, Yuly Bersudsky, and R. H. Belmaker
[Abstract] [PDF]

591 Pain Predicts Longer Time to Remission During Treatment of Recurrent Depression. Jordan F. Karp, John Scott, Patricia Houck, Charles F. Reynolds III, David J. Kupfer, and Ellen Frank
[Abstract] [PDF]

598 An 8-Week Open-Label Trial of a 6-Day Course of Mifepristone for the Treatment of Psychotic Depression. George M. Simpson, Adel El Sheshai, Nasser Loza, Steven J. Kingsbury, Mohamed Fayek, Ahmed Rady, and Waleed Fawzy
[Abstract] [PDF]

603 Why Isn't Bupropion the Most Frequently Prescribed Antidepressant? Mark Zimmerman, Michael A. Posternak, Naureen Attiullah, Michael Friedman, Robert J. Boland, Scott Baymiller, Stacie Lauro Berlowitz, Shahzad Rahman, Kirsten K. Uy, Steve Singer, and Iwona Chelminski
[Abstract] [PDF]

611 Analyses of Treatment-Emergent Mania With Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression. Paul E. Keck, Jr., Sara A. Corya, Lori L. Altshuler, Terence A. Ketter, Susan L. McElroy, Michael Case, Susan D. Briggs, and Mauricio Tohen
[Abstract] [PDF]

617 Open-Label Adjunctive Zonisamide in the Treatment of Bipolar Disorders: A Prospective Trial. Susan L. McElroy, Trisha Suppes, Paul E. Keck, Jr., David Black, Mark A. Frye, Lori L. Altshuler, Willem A. Nolen, Ralph W. Kupka, Gabriele S. Leverich, Jorg Walden, Heinz Grunze, and Robert M. Post
[Abstract] [PDF]

625 Prospective Observational Study of Treatments for Unexplained Chronic Fatigue. Suzanne E. Bentler, Arthur J. Hartz, and Evelyn M. Kuhn
[Abstract] [PDF]

633 Neuroleptic Sensitivity in Parkinson's Disease and Parkinsonian Dementias. Dag Aarsland, Robert Perry, Jan P. Larsen, Ian G. McKeith, John T. O'Brien, Elaine K. Perry, David Burn, and Clive G. Ballard
[Abstract] [PDF]

638 Long-Term Maintenance Therapy With Quetiapine Versus Haloperidol Decanoate in Patients With Schizophrenia or Schizoaffective Disorder. Ira D. Glick and Stephen R. Marder
[Abstract] [PDF]

642 Dermatology Precautions and Slower Titration Yield Low Incidence of Lamotrigine Treatment-Emergent Rash. Terence A. Ketter, Po W. Wang, Rebecca A. Chandler, Andrea M. Alarcon, Olga V. Becker, Cecylia Nowakowska, Colette M. O'Keeffe, and Matthew R. Schumacher
[Abstract] [PDF]

646 Factors Associated With Medication Adherence in African American and White Patients With Bipolar Disorder. David E. Fleck, Paul E. Keck, Jr., Kimberly B. Corey, and Stephen M. Strakowski
[Abstract] [PDF]

ASCP Corner

653 Reading Reports of Clinical Trial Results. John M. Kane
[PDF]

Letters To the Editor

654 Use of Olanzapine in Anorexia Nervosa. Michael Menaster · Reply by Nicole C. Barbarich-Marsteller and Walter H. Kaye
[PDF]

656 Injection Site Pain With Long-Acting Risperidone. Narsimha R. Pinninti and Rajnish Mago · Reply by Jean-Pierre Lindenmayer, Els Eerdekens, and Mariëlle Eerdekens
[PDF]

657 Do Antihypertensives Make Tranylcypromine Safer? Three Case Reports. Bonnie P. Taylor, Frederic M. Quitkin, Patrick J. McGrath, and Jonathan W. Stewart
[PDF]

658 Development of Subtle Psychotic Symptoms With Memantine: A Case Report. Edward D. Huey, Irene H. Dustin, Gerald P. Overman, Nadeem Mirza, and Trey Sunderland
[PDF]

659 Correction. Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, and Kalali AH, for the SPD417 Study Group. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial (J Clin Psychiatry 2005;66:323-330)
[PDF]

Book Review 660